Stock CTX CAPTOR THERAPEUTICS SPOLKA AKCYJNA
Add to a list
To use this feature you must be a member
Log inSign up

News Captor Therapeutics Spolka Akcyjna

Equities

CTX

PLCPTRT00014

Delayed Warsaw S.E.
Other stock markets
 11:20:07 13/05/2024 BST 		5-day change 1st Jan Change
75.2 PLN -1.57% Intraday chart for Captor Therapeutics Spolka Akcyjna -6.00% -24.04%
2023 Captor Therapeutics Spolka Akcyjna Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
2023 Captor Therapeutics Spolka Akcyjna Reports Earnings Results for the Half Year Ended June 30, 2023 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Captor Therapeutics Spolka Akcyjna Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Captor Therapeutics Spolka Akcyjna Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Captor Therapeutics Publishes Q1 2023 Financial Results
AQ
Captor Therapeutics Spolka Akcyjna Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Captor Therapeutics Spolka Akcyjna Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Captor Therapeutics Discloses Molecular Targets of Pipeline’s Lead Assets and Invites Stakeholders to Webcast
AQ
Captor Therapeutics Announces Three-Year Strategic Objectives
AQ
Captor Therapeutics Reports Q3 2022 Results and Provides Business UpdateLead assets approaching the clinic and new significant drug discovery collaboration signed with Ono Pharmaceutical
AQ
Captor Therapeutics Reports Q3 2022 Results and Provides Business Update
AQ
Captor Therapeutics Spolka Akcyjna Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
Ono Enters a Drug Discovery Collaboration Agreement with Captor Therapeutics to Develop Small Molecule Protein Degraders for the Treatment of Neurodegenerative Diseases
AQ
Ono Pharmaceutical and Captor Therapeutics Announce Drug Discovery Collaboration to Develop Small Molecule Protein Degraders for the Treatment of Neurodegenerative Diseases
AQ
Ono Pharmaceutical and Captor Therapeutics Announces Drug Discovery Collaboration to Develop Small Molecule Protein Degraders for the Treatment of Neurodegenerative Diseases
CI
Captor Therapeutics Nominates the Molecular Glue CPT-6281 as Drug Candidate to Enter CTA/IND-Enabling Studies for the Treatment of Hepatocellular Carcinoma
AQ
Captor Therapeutics S.A. Nominates the Molecular Glue CPT-6281 as Drug Candidate to Enter CTA/IND-Enabling Studies for the Treatment of Hepatocellular Carcinoma
CI
Captor Therapeutics to Host R&D Day on May 18, 2022
GL
Captor Therapeutics to Host R&D Day on May 18, 2022
AQ
Captor Therapeutics announces molecular targets of CT-01 program developing TPD therapy for hepatocellular carcinoma
AQ
Captor Therapeutics S.A. Announces Molecular Targets of CT-01 Program Developing TPD Therapy for Hepatocellular Carcinoma
CI
Certain Ordinary Bearer Shares of Captor Therapeutics Spolka Akcyjna are subject to a Lock-Up Agreement Ending on 12-APR-2022.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CTX Stock
  4. News Captor Therapeutics Spolka Akcyjna